Trials / Completed
CompletedNCT01843621
A Phase I/II Trial of a Tetravalent Live Attenuated DEN Vaccine in Flavivirus Antibody Naive Children
A Phase I/II, Open, Five-year, Clinical Follow-up Study of Thai Children Who Participated in Dengue-003 ("A Phase I/II Trial of a Tetravalent Live Attenuated DEN Vaccine in Flavivirus Antibody Naive Children") With Evaluation of a Booster Dose Given One Year After Primary DEN Vaccination Series
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 7 (actual)
- Sponsor
- U.S. Army Medical Research and Development Command · Federal
- Sex
- All
- Age
- 6 Years – 9 Years
- Healthy volunteers
- Accepted
Summary
One year follow-up on immunogenicity and safety of a booster dose of DEN vaccine administered approx. 1 year following the second dose
Detailed description
The purpose of this study is to find out more about the two doses of dengue vaccine, over a five year period, that the children received in the Dengue-003 study and to study a third dose of dengue that will be given to the children * Do children still have dengue antibodies intended to provide protection against dengue infection one year after the two doses of vaccine given in study Dengue-003? * Were there any major medical problems that appeared as dengue-like symptoms during the one year after vaccinations? * Will a third dose of dengue help to further stimulate the part of the immune system intended to help protect against dengue infection? * Is a third dose as safe as the first two doses? * Are the local reactions to a third dose of the vaccine similar to what your child experienced after the first two doses?
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | DEN vaccine F17 | The dengue booster vaccine was administered subcutaneously in the non-dominant arm (deltoid). The tetravalent, live attenuated DEN F17 vaccine was administered in this study. This pre-transfection formulation contained dengue virus types 1, 2, 3 and 4 (DEN-1, -2, -3 and -4). |
Timeline
- Start date
- 2005-02-01
- Primary completion
- 2005-02-01
- Completion
- 2009-02-01
- First posted
- 2013-04-30
- Last updated
- 2018-11-26
- Results posted
- 2018-11-26
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT01843621. Inclusion in this directory is not an endorsement.